1,600+ AI-Enabled Medical Devices: 7 Questions to Ask Before Adding AI to Your Product

The FDA has authorized more than 1,600 AI-enabled medical devices for marketing in the United States as of September 2026. For medical device startups, adding AI can improve diagnostic capabilities, clinical workflows and product performance. However, it also introduces challenges involving clinical data, validation, usability, hardware integration, regulatory requirements and long-term costs.

For founders developing AI-enabled medical devices, understanding these implications early can influence both product development timelines and commercial success.

AI in Medical Devices: Why the Conversation Has Changed

Imagine a medical device startup developing a portable diagnostic system.

The engineering team has built a functional prototype. Initial testing is encouraging, and clinicians have started providing feedback.

During a product review, someone suggests adding AI to automatically interpret the readings.

It sounds like a logical next step. AI could improve the product's capabilities, strengthen its market positioning and potentially attract investor interest.

But incorporating an AI model also changes the product's technical requirements. The team may need additional data, computing resources, software validation and a different approach to regulatory planning.

This is becoming an increasingly common consideration in medical device development.

According to the US Food and Drug Administration (FDA), more than 1,600 AI-enabled medical devices had been authorized for marketing in the United States by September 2026.

These include technologies that support medical imaging, diabetic retinopathy detection, cardiovascular assessment and automated insulin dosing.

The number demonstrates how widely artificial intelligence is being adopted in healthcare. However, the FDA's list is not exhaustive, and authorization does not necessarily indicate how widely a particular device is used in clinical practice.

At Inspire Design, our experience across 60+ healthcare product development projects has reinforced the importance of understanding the clinical problem before selecting the technology.

AI has considerable potential, but its inclusion should be based on the value it creates for the intended users.

Here are seven questions medical device founders should consider before incorporating AI into a new or existing healthcare product.

1. Does Your Medical Device Actually Need AI?

AI should be introduced when it addresses a specific clinical or operational problem that justifies the additional development effort.

Consider a diagnostic device that captures and displays patient information.

If clinicians can already interpret the information effectively, introducing AI may not automatically improve the workflow.

However, an algorithm capable of identifying subtle abnormalities, prioritising cases or reducing interpretation time could provide meaningful value.

A relevant example is IDx-DR, an AI-based diagnostic system authorized by the FDA in 2018 for detecting more-than-mild diabetic retinopathy in adults with diabetes.

In the pivotal study supporting its authorization, the system demonstrated:

• 87.4% sensitivity

• 89.5% specificity

The significance of this example lies in its clearly defined clinical application and evaluated performance.

For startups developing AI-powered diagnostic devices, similar clarity is essential.

Before investing in AI development, companies should identify the clinical problem, establish how it is currently managed and define what improvement the technology is expected to deliver.

A feature that does not meaningfully improve clinical performance, usability or operational efficiency may be difficult to justify commercially.

2. Is Your Clinical Data Suitable for AI Medical Device Development?

Data quality, representativeness and clinical relevance are fundamental to developing reliable AI-enabled medical devices.

A model trained using data from a limited number of hospitals may perform differently when deployed across other patient populations, equipment configurations or healthcare settings.

For Indian medical device startups planning to enter international markets, this is particularly relevant.

An algorithm developed using data collected in one geography may require additional evaluation before its performance can be established for another intended population.

In 2021, the FDA, Health Canada and the UK's Medicines and Healthcare products Regulatory Agency published 10 guiding principles for Good Machine Learning Practice (GMLP).

The principles address representative datasets, appropriate separation of training and testing data, clinically relevant performance evaluation and monitoring of deployed models.

These considerations have direct implications for medical device development costs.

A startup may have access to thousands of medical images or sensor readings. However, the usefulness of that data depends on whether it adequately represents the device's intended use.

Data collection, annotation, access rights, quality checks and clinical evaluation should therefore be considered during early product feasibility planning.

For AI-enabled medical devices, having more data does not necessarily mean having better data.

3. How Will You Validate the Safety and Performance of Your AI Medical Device?

AI medical device validation involves demonstrating that the complete device performs appropriately for its intended clinical use, not simply that its algorithm achieves a high accuracy score.

A company may report that its AI model is 95% accurate.

Without additional context, that figure provides limited information about clinical suitability.

Depending on the application, sensitivity, specificity, false-positive rates and false-negative rates may be more relevant.

For example, a diagnostic algorithm that misses clinically significant findings presents different risks from one that generates excessive false alerts.

Both can affect clinical decision-making.

In January 2025, the FDA published draft guidance on lifecycle management and marketing submissions for AI-enabled device software functions.

The guidance addresses considerations involving performance evaluation, risk management, transparency, bias and documentation.

Medical device developers must also consider how users interact with AI-generated outputs.

If a device produces a risk score or diagnostic recommendation, clinicians need sufficient information to interpret and use it appropriately.

The interface should communicate relevant limitations, warnings and required actions without creating unnecessary confusion.

For companies developing AI-based diagnostic equipment, validation planning should therefore involve clinical expertise, software engineering, risk management and human-factors considerations.

These activities are closely connected to the overall medical device design process.

4. Will AI Improve the Usability of Your Medical Device?

An AI-enabled medical device must work effectively within the clinical environment for which it is intended.

Consider a portable diagnostic device used in an outpatient clinic.

The original product allows a clinician to capture a reading, review the result and proceed with the appropriate clinical action.

The development team introduces AI-generated risk categories, confidence indicators and additional recommendations.

Although the technology may provide more information, it can also make the interface more complicated.

The clinician now needs to interpret several outputs instead of one.

This raises important medical device usability questions.

How quickly can the user understand the information? Are alerts prioritised appropriately? Can the user recognise when additional clinical assessment is necessary?

Does the new feature reduce the time required to complete the task?

These considerations influence software interfaces, displays, physical controls and overall product design.

Industrial design and human-factors engineering play an important role in ensuring that sophisticated technology remains practical to use.

For medical device startups, AI integration should be evaluated as part of the complete user experience rather than as an independent software feature.

5. Can Your Medical Device Support Future AI Software Updates?

AI-enabled medical devices may require software modifications throughout their commercial lifecycle.

New data, performance improvements, cybersecurity requirements or identified limitations can create the need for updates.

These changes must be managed through appropriate development, validation and regulatory processes.

In August 2025, the FDA issued final guidance on Predetermined Change Control Plans (PCCPs) for AI-enabled device software functions.

A PCCP can describe planned modifications, the methods used to develop and validate those changes, and an assessment of their potential impact.

When an appropriate PCCP is authorized, specified modifications may be implemented without a separate marketing submission for every covered change.

This development highlights the importance of planning for software evolution.

For manufacturers, future updates can affect product architecture, computing requirements, memory, connectivity and version management.

A device designed only around its initial algorithm may encounter limitations when new capabilities are introduced.

For example, an AI feature requiring additional processing capacity could affect power consumption, battery performance and thermal management.

These decisions may eventually influence PCB design, enclosure dimensions and component selection.

Considering the software lifecycle during early engineering can help reduce the need for major product redesigns.

6. What Is the Real Cost of Developing an AI-Enabled Medical Device?

The cost of AI medical device development includes much more than algorithm development.

Depending on the product, companies may need to budget for:

• Clinical data collection, preparation and annotation

• AI model development, testing and evaluation

• Software engineering and hardware integration

• Verification, validation and clinical evaluation

• Cybersecurity and data protection

• Regulatory submissions and quality-system activities

• Software maintenance and post-market performance monitoring

The final cost depends on the device's intended use, complexity, regulatory pathway and existing technical infrastructure.

For example, a medical device performing AI processing locally may require a more powerful processor and additional memory.

This can influence PCB architecture, power consumption, heat dissipation and battery life.

A cloud-based system may have different requirements involving connectivity, data transfer, latency and security.

These engineering decisions can affect the product's manufacturing cost and long-term commercial viability.

For early-stage medical device startups, it is useful to compare the total development cost of an AI-enabled product with an alternative that addresses the same clinical problem without AI.

The additional investment should be supported by an identifiable clinical or operational benefit.

7. Will AI Make Your Medical Device More Competitive?

The increasing number of FDA-authorized AI-enabled medical devices indicates that AI is becoming an established part of medical technology.

However, the commercial value of AI depends on the problem being addressed and the healthcare environment in which the device will be used.

The FDA's authorized device list includes technologies based on machine learning, image analysis, pattern recognition and other AI approaches.

These should not be confused with generative AI applications, which may have different technical characteristics and risk considerations.

For medical device manufacturers, the distinction matters.

Hospitals and healthcare providers evaluating a new device may consider clinical performance, reliability, workflow integration, training requirements, maintenance, service support and total cost of ownership.

AI may strengthen the product's value proposition when it contributes to these outcomes.

For example, an algorithm that helps reduce interpretation time or supports the detection of clinically important findings could provide a meaningful advantage.

However, an AI feature that does not change clinical or operational outcomes may increase development complexity without creating sufficient commercial value.

For founders, competitive differentiation should be assessed through the benefits delivered by the finished medical device rather than the presence of AI alone.

What Should Medical Device Startups Consider Be

fore Adding AI?

For founders evaluating AI in medical device product development, seven areas deserve early attention: clinical need, data readiness, validation, usability, software lifecycle, development cost and commercial value.

These factors are interconnected.

An AI algorithm that requires greater processing capacity can influence hardware design. A new diagnostic output may change the user interface. Additional clinical validation requirements can affect development timelines. Future software updates may influence connectivity and product architecture.

Addressing these considerations during the concept and prototyping stages can help medical device companies make better engineering decisions.

The FDA's 1,600+ authorized AI-enabled devices demonstrate that the technology has already established meaningful applications across healthcare.

The opportunity for startups is to identify where AI can make their products genuinely more useful.

That requires a clear understanding of clinical needs, technical feasibility and the realities of bringing a medical device to market.

How Inspire Design Supports Medical Device Product Development

At Inspire Design, we have worked across 60+ healthcare product development projects, supporting clinicians, startups and medical device companies through industrial design, product engineering, prototyping and Design for Manufacturing.

As medical devices incorporate more sophisticated electronics and software, product development requires coordination across hardware, usability, engineering and manufacturing requirements.

For companies developing AI-enabled medical devices, these considerations are particularly important because software capabilities can influence the physical and technical architecture of the product.

Our focus is on helping healthcare innovators develop products that are practical to use, technically feasible and designed with manufacturing requirements in mind.

If you're developing a new medical device or considering additional capabilities for an existing product, our team can help you evaluate the product design and engineering requirements.

Frequently Asked Questions About AI-Enabled Medical Devices

1. What is an AI-enabled medical device?

An AI-enabled medical device is a medical device that incorporates artificial intelligence to perform or support functions such as medical image analysis, disease detection, patient monitoring or clinical decision support. Its regulatory status depends on its intended use and applicable medical device requirements.

2. How many AI-enabled medical devices has the FDA authorized?

As of September 2026, the FDA reported authorizing more than 1,600 AI-enabled medical devices for marketing in the United States. The FDA maintains a periodically updated public list, although it is not a comprehensive record of every AI-enabled device.

3. What are the main challenges in AI medical device development?

The main challenges include obtaining representative clinical data, validating performance, managing errors and bias, integrating AI with hardware and software, ensuring usability, meeting regulatory requirements and maintaining the device throughout its lifecycle.

4. Does an AI-enabled medical device need FDA approval?

Not every AI-enabled medical device follows the same regulatory pathway. Depending on the device's classification and intended use, applicable FDA pathways may include 510(k) clearance, De Novo authorization or premarket approval. Certain software functions may fall outside medical device regulation.

5. How much does it cost to develop an AI-enabled medical device?

There is no universal development cost. The budget depends on algorithm complexity, data availability, hardware requirements, clinical evaluation, regulatory activities, manufacturing considerations and ongoing software maintenance.

6. Can AI be added to an existing medical device?

Yes, but adding AI may change the device's intended functionality, software architecture, hardware requirements, risk profile and regulatory obligations. The impact should be assessed before development begins.

7. Why is product design important for AI-enabled medical devices?

Product design ensures that AI capabilities are integrated into a usable, reliable medical device. It influences physical ergonomics, hardware architecture, interfaces, clinical workflows and manufacturability.

Disclaimer: This article is for general educational purposes and does not constitute medical, regulatory or legal advice. Requirements depend on the device, intended use and target market.

About the Author

Kunal Bijlani is the Co-founder of Inspire Design, a product design and engineering company working with clinicians, healthcare startups and medical device manufacturers.

Through the company's work across 60+ healthcare product development projects, he has supported teams through product design, engineering, prototyping and Design for Manufacturing.

His focus is on helping healthcare innovators translate early-stage concepts into practical, well-engineered products.